Core Insights - Constellation Brands, Inc. (STZ) is a significant player in the U.S. beverage-alcohol market, with a market capitalization of $25.1 billion, producing and distributing well-known brands like Corona and Modelo [1][2] Company Overview - Founded in 1945 and headquartered in New York, STZ holds exclusive U.S. rights to several iconic beer brands, reinforcing its strong brand equity and market position [1] - As a large-cap stock, STZ's market cap exceeding $10 billion highlights its influence and dominance in the beverages-brewers industry [2] Stock Performance - STZ has experienced a significant decline, down 43.8% from its 52-week high of $245.31, and has underperformed the S&P 500 Index, which surged 6.5% over the past three months [3][4] - Over the past 52 weeks, STZ shares have fallen 42%, compared to a 12.9% decline in the S&P 500, and year-to-date, STZ is down 37.6% versus the S&P 500's 16.1% drop [4] Recent Financial Results - On October 6, STZ reported fiscal second-quarter results with net sales of $2.5 billion, a 15% year-over-year decline, but slightly above analyst expectations [5] - Adjusted EPS fell 16% to $3.63, beating the consensus estimate of $3.37, yet investor sentiment remained cautious, leading to a 2.5% drop in shares on the announcement day [5] Competitive Landscape - STZ has significantly lagged behind its competitor Anheuser-Busch InBev SA/NV (BUD), which saw a 13.9% increase over the past 52 weeks and a 23.1% gain year-to-date [6]
Is Constellation Brands Stock Underperforming the S&P 500?